We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OK ON ATON PUTS MERCK BACK IN CANCER DRUG MARKET
OK ON ATON PUTS MERCK BACK IN CANCER DRUG MARKET
March 19, 2004
Federal regulators have approved Merck’s acquisition of privately held biotech company Aton Pharma, clearing the way for Merck to re-enter the cancer drug market after a 34-year hiatus.